Kajikawa Akinobu, Satoh Eiichi, Leer Rob J, Yamamoto Shigeki, Igimi Shizunobu
Division of Biomedical Food Research, National Institute of Health Sciences, Tokyo, Japan.
Vaccine. 2007 May 4;25(18):3599-605. doi: 10.1016/j.vaccine.2007.01.055. Epub 2007 Jan 22.
A recombinant Lactobacillus casei expressing a flagellar antigen from Salmonella enterica serovar Enteritidis was constructed and evaluated as a mucosal vaccine. Intragastric immunization of the recombinant strain conferred protective immunity against Salmonella infection in mice. This immunization did not result in antigen-specific antibody in either feces or sera but induced the release of IFN-gamma on restimulation of primed lymphocytes ex vivo. The results suggested that the protective efficacy provided by flagellin-expressing L. casei is mainly attributable to cell-mediated immune responses. In addition, an adjuvant-type effect of the antigen delivery system with L. casei was also observed.
构建了一种表达肠炎沙门氏菌鞭毛抗原的重组干酪乳杆菌,并将其作为黏膜疫苗进行评估。对重组菌株进行胃内免疫可使小鼠获得针对沙门氏菌感染的保护性免疫。这种免疫在粪便或血清中均未产生抗原特异性抗体,但在体外再次刺激致敏淋巴细胞时可诱导γ干扰素的释放。结果表明,表达鞭毛蛋白的干酪乳杆菌提供的保护效力主要归因于细胞介导的免疫反应。此外,还观察到干酪乳杆菌作为抗原递送系统的佐剂样效应。